Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.

Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.

Human arylamine N-acetyltransferase 1 (NAT1) has been overexpressed in E. coli as a mutant dihydrofolic acid reductase (DHFR) fusion protein with a thrombin sensitive linker. An initial DEAE anion-exchange chromatography resulted in partial purification of the fusion protein. The fusion protein was...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Wang, H, Vath, G, Kawamura, A, Bates, C, Sim, E, Hanna, P, Wagner, C
Format:	Journal article
Język:	English
Wydane:	2005

Podobne zapisy

Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
od: Kawamura, A, i wsp.
Wydane: (2005)

Neuroendocrine expression of mouse arylamine N-acetyltransferase 2
od: Wakefield, L, i wsp.
Wydane: (2006)

Structure and mechanism of arylamine N-acetyltransferases.
od: Westwood, I, i wsp.
Wydane: (2006)

Arylamine N-acetyltransferase in adult mouse brain
od: Mo, M, i wsp.
Wydane: (2004)

Hamster arylamine N-acetyltransferase 2: Investigation of substrate specificity by high-through-put screening
od: Kawamura, A, i wsp.
Wydane: (2004)

Expression of the genes for arylamine N-acetyltransferases in mice
od: Boukouvala, S, i wsp.
Wydane: (2002)

Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
od: Sim, E, i wsp.
Wydane: (2008)

Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
od: Laurieri, N, i wsp.
Wydane: (2014)

Arylamine N-acetyltransferase expression during murine heart development
od: Wakefield, L, i wsp.
Wydane: (2004)

Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
od: Kawamura, A, i wsp.
Wydane: (2003)

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
od: Russell, A, i wsp.
Wydane: (2009)

Structural Studies on the Mycobacterial Arylamine N-Acetyltransferases
od: Abuhammad, A, i wsp.
Wydane: (2010)

Mapping the genes for arylamine N-acetyltransferases
od: Fakis, G
Wydane: (2000)

Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
od: Fullam, E, i wsp.
Wydane: (2009)

An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
od: Brooke, E, i wsp.
Wydane: (2003)

Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.
od: Anderton, M, i wsp.
Wydane: (2006)

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
od: Westwood, I, i wsp.
Wydane: (2010)

Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
od: Westwood, I, i wsp.
Wydane: (2011)

Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
od: Abuhammad, A, i wsp.
Wydane: (2010)

Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system.
od: Wakefield, L, i wsp.
Wydane: (2008)

Characterization of the putative operon containing arylamine N−acetyltransferase (nat) in Mycobacterium bovis BCG
od: Eltis, E
Wydane: (2006)

The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
od: Sandy, J, i wsp.
Wydane: (2002)

Protein-ligand interactions of arylamine N-acetyltransferase from Mycobacterium smegmatis
od: Brooke, E
Wydane: (2003)

Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarker.
od: Laurieri, N, i wsp.
Wydane: (2010)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
od: Madikane, V, i wsp.
Wydane: (2007)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris
od: Madikane, V, i wsp.
Wydane: (2007)

Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1.
od: Kawamura, A, i wsp.
Wydane: (2008)

Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.
od: Adam, P, i wsp.
Wydane: (2003)

Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
od: Brooke, E, i wsp.
Wydane: (2003)

Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages
od: Abuhammad, A, i wsp.
Wydane: (2012)

Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis.
od: Fakis, G, i wsp.
Wydane: (2007)

Arylamine N-Acetyltransferases from mycobacteria: investigations of a potential yarget for anti-tubercular therapy
od: Abuhammad, A
Wydane: (2013)

A novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1
od: Laurieri, N, i wsp.
Wydane: (2013)

Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity.
od: Abuhammad, A, i wsp.
Wydane: (2013)

Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
od: Fullam, E, i wsp.
Wydane: (2013)

Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
od: Fullam, E, i wsp.
Wydane: (2013)

Expression of arylamine N-acetyl transferase in the developing heart
od: Wakefield, L, i wsp.
Wydane: (2004)

Summary of case study lecture at Biophysics and Structural Biology at Synchrotrons Workshop Triumph over Adversity: structure of arylamine N-acetyltransferase from M. tuberculosis
od: Garman, E
Wydane: (2019)

Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2.
od: Fakis, G, i wsp.
Wydane: (2000)

Expression and purification of recombinant neurotensin in Escherichia coli.
od: Williamson, P, i wsp.
Wydane: (2000)